Citation

Maj M. Bipolar Disord. 2003; 5(3): 180-188.

Copyright

(Copyright © 2003, John Wiley and Sons)

DOI

10.1034/j.1399-5618.2003.00002.x

PMID

12780872

Abstract

Recently published clinical research on lithium is briefly reviewed. The antimanic effect of lithium is supported by recent evidence. It is confirmed that a drastic reduction of affective morbidity is very frequent in bipolar patients receiving lithium prophylaxis regularly for several years, but that the impact of prophylaxis on the course of bipolar disorder is significantly limited by the high drop-out rate. Lithium does seem to be efficacious also in bipolar disorder with mood-incongruent psychotic features or with rapid cycling. The effect of lithium prophylaxis does not seem to decrease over time, at least in the large majority of patients. The recurrence risk is increased in the months following lithium discontinuation. Lithium seems to exert an antisuicidal effect in bipolar patients.

Language: en

Keywords

Antimanic Agents; Bipolar Disorder; Humans; Lithium Compounds; Prognosis; Suicide Prevention; Treatment Refusal